These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16849741)

  • 1. Treatment complications in neuroblastoma patients: lessons from screening studies.
    Kerbl R; Urban CE; Zotter H; Dornbusch HJ; Ladenstein R; Ambros IM; Ambros PF
    J Clin Oncol; 2006 Jul; 24(21):e41. PubMed ID: 16849741
    [No Abstract]   [Full Text] [Related]  

  • 2. The child with neuroblastoma.
    Pochedly CE
    Am Fam Physician; 1972 Feb; 5(2):74-9. PubMed ID: 5018592
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment complications in children diagnosed with neuroblastoma during a screening program.
    Barrette S; Bernstein ML; Leclerc JM; Champagne MA; Samson Y; Brossard J; Woods WG
    J Clin Oncol; 2006 Apr; 24(10):1542-5. PubMed ID: 16575005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical appearance of neuroblastoma 10 years after screening.
    Kerbl R; Urban CE; Zotter H; Lackner H; Sovinz P; Ambros PF
    Pediatr Blood Cancer; 2007 Dec; 49(7):1012-4. PubMed ID: 16534792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
    Matthay KK; Yanik G; Messina J; Quach A; Huberty J; Cheng SC; Veatch J; Goldsby R; Brophy P; Kersun LS; Hawkins RA; Maris JM
    J Clin Oncol; 2007 Mar; 25(9):1054-60. PubMed ID: 17369569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined therapy of neuroblastoma.
    Van Way CW; Carlisle RB; Stephenson SE
    Ann Surg; 1968 Jun; 167(6):856-66. PubMed ID: 5652371
    [No Abstract]   [Full Text] [Related]  

  • 7. Staging and treatment of neuroblastoma.
    Evans AE
    Cancer; 1980 Apr; 45(7 Suppl):1799-1802. PubMed ID: 7370930
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutical aspects of the neuroblastoma (author's transl)].
    Schietzel M; Firusian N
    Strahlentherapie; 1980 May; 156(5):308-14. PubMed ID: 7394845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the right treatments for neuroblastoma.
    Nelson NJ
    J Natl Cancer Inst; 2011 Aug; 103(16):1218-21. PubMed ID: 21813407
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Incidental detection of neuroblastoma and "Wait and See" strategy.
    D'Angio GJ
    Pediatr Blood Cancer; 2005 Oct; 45(5):735; author reply 736. PubMed ID: 16047347
    [No Abstract]   [Full Text] [Related]  

  • 11. Disease control intervals in high-risk neuroblastoma.
    Santana VM; Furman WL; McGregor LM; Billups CA
    Cancer; 2008 Jun; 112(12):2796-801. PubMed ID: 18429000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroblastoma trial to overcome a rare malignant disease].
    Fukushima T; Shichino H; Kumagai M
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):167-74. PubMed ID: 17301522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).
    ; Villablanca JG; Krailo MD; Ames MM; Reid JM; Reaman GH; Reynolds CP
    J Clin Oncol; 2006 Jul; 24(21):3423-30. PubMed ID: 16849757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late complications after surgery in patients with neuroblastoma.
    Kuroda T; Saeki M; Honna T; Kumagai M; Masaki H
    J Pediatr Surg; 2006 Dec; 41(12):2037-40. PubMed ID: 17161200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34+ selection in childhood advanced neuroblastoma.
    Cai JY; Tang YJ; Jiang LM; Pan C; Chen J; Tang JY
    Pediatr Blood Cancer; 2007 Dec; 49(7):952-7. PubMed ID: 17514736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant solid tumors in neonates: a study of 71 cases].
    de Bouyn-Icher C; Minard-Colin V; Isapof A; Khuong Quang DA; Redon I; Hartmann O
    Arch Pediatr; 2006 Dec; 13(12):1486-94. PubMed ID: 17137765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004.
    Schmidt M; Simon T; Hero B; Eschner W; Dietlein M; Sudbrock F; Bongartz R; Berthold F; Schicha H
    Nuklearmedizin; 2006; 45(4):145-51; quiz N39-40. PubMed ID: 16964339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroblastoma in childhood: review and radiological findings.
    Papaioannou G; McHugh K
    Cancer Imaging; 2005 Sep; 5(1):116-27. PubMed ID: 16305949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of sympathetic neuroblastoma in children].
    Bozek J; Zaorska B
    Pediatr Pol; 1966 Jul; 41(7):797-803. PubMed ID: 5928329
    [No Abstract]   [Full Text] [Related]  

  • 20. Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age.
    de Kraker J; Hoefnagel KA; Verschuur AC; van Eck B; van Santen HM; Caron HN
    Eur J Cancer; 2008 Mar; 44(4):551-6. PubMed ID: 18267358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.